Cancer type | Dose (Gy) | BED \(\infty\) (Gy) | BEDexp (Gy) | TCP (%) | \(\Delta {\text{TLG}}_{{{\text{liver}}}}\)(%) |
---|---|---|---|---|---|
Breast | 47.7 | 58.0 | 41.5 | 41.7 | 43.6 |
PNET | 51.4 | 56.8 | 45.3 | 44.2 | 48.8 |
Adrenocortical carcinoma | 52.7 | 67.7 | 26.2 | 17.6 | 23.7 |
CRC | 127 | 170 | 90.1 | 65.6 | 75.5 |
Cholangiocarcinoma | 28.1 | 46.2 | 46.1 | 50.6 | 56.9 |
CRC | 33.3 | 37.6 | 6.03 | 0.12 | − 113 |
CRC | 42.6 | 53.0 | 43.3 | 42.8 | 47.7 |
Rectal adenocarcinoma | 12.3 | 12.9 | 12.6 | 20.4 | 25.8 |
Cholangiocarcinoma | 34.0 | 51.3 | 51.3 | 82.5 | 98.6 |
CRC | 33.2 | 37.0 | 8.10 | 0.10 | − 9.73 |
Cholangiocarcinoma | 272 | 554 | 11.8 | 7.31 | 16.0 |
Cholangiocarcinoma | 39.3 | 74.6 | 73.6 | 71.9 | 82.6 |
Sigmoid adenocarcinoma | 53.0 | 62.7 | 61.9 | 54.6 | 70.3 |
Breast | 45.6 | 93.0 | 93.0 | 79.1 | 89.0 |
Prostate | 62.6 | 107 | 107 | 82.0 | 96.0 |
mCRC | 29.5 | 34.2 | 32.7 | 32.1 | 37.5 |
PNET | 42.2 | 60.9 | 60.7 | 50.8 | 57.0 |
PDAC | 8.84 | 47.8 | 47.8 | 45.0 | 58.3 |
SBNET | 231 | 368 | 368 | 81.3 | 85.1 |
Mesothelioma | 59.9 | 62.5 | 69.9 | 60.6 | 65.7 |
PNET | 97.8 | 116 | 116 | 72.8 | 80.3 |
HCC | 80.6 | 134 | 12.5 | 0.27 | 0.15 |
Oesophageal | 37.7 | 63.6 | 63.5 | 51.7 | 62.0 |
SBNET | 50.0 | 55.1 | 40.3 | 31.5 | 35.0 |
NEC | 17.1 | 21.9 | 10.5 | 0.32 | − 2.29 |